Rocky Mountain Cancer Centers (RMCC) - Boulder — Boulder, Colorado

Rocky Mountain Cancer Centers (RMCC) - Boulder is a clinical research site located in Boulder, Colorado, United States 80303.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers (RMCC) - Boulder has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.

Sponsors: Epizyme, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers (RMCC) - Boulder?

Rocky Mountain Cancer Centers (RMCC) - Boulder has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers (RMCC) - Boulder conducted?

Rocky Mountain Cancer Centers (RMCC) - Boulder has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.

Is Rocky Mountain Cancer Centers (RMCC) - Boulder accredited by Crixeo Health?

Rocky Mountain Cancer Centers (RMCC) - Boulder has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers (RMCC) - Boulder?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.